about
IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE)Tolerizing allergic responses in the lung.Efficacy and safety of allergen-specific immunotherapy in rhinitis, rhinoconjunctivitis, and bee/wasp venom allergies.Sublingual immunotherapy of allergic diseases.Novel therapeutic interventions for allergic rhinitis.New approaches to managing asthma: a US perspectiveUndertreatment of allergy: exploring the utility of sublingual immunotherapy.Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.Novel routes for allergen immunotherapy: safety, efficacy and mode of action.Recent developments in buccal and sublingual delivery systems.Sublingual immunotherapy in preschool children: an update.Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications.A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair).Sublingual immunotherapy in patients with house dust mite allergic rhinitis: prospective study of clinical outcomes over a two-year period.Effects of sublingual immunotherapy for Dermatophagoides farinae on Th17 cells and CD4(+) CD25(+) regulatory T cells in peripheral blood of children with allergic asthma.Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy
P2860
Q33525565-4286A944-EFC7-449A-9438-DE28922D7E8DQ36054136-9EFE9747-01E8-4FD6-AE26-D775115E76F5Q36327394-34B2F001-8635-4415-ABCE-76575AD5EACDQ36583727-01770F60-2A46-4E7D-8151-139211B40F12Q36654345-4C3DB785-6AC3-4D33-99BA-DE640425303AQ36823534-71F0651A-7B16-4BE8-8720-7F034188AB0DQ37459337-47DF3406-3B01-47CF-B71E-FEAA1C8CD3E0Q37888684-EAF20F41-B261-4E35-8FF7-C46CCB280F19Q37984572-5FC857A6-E1C2-4163-81B7-D3B8A2158439Q38003422-43BAEE6F-B4F8-43FE-A314-E829938A5535Q38096032-B6C0C113-3576-4367-9A87-A77D795E4ACFQ38113269-439A24DA-7105-47C7-A23F-9C2DE2AE08D3Q38262772-B9578699-9089-4F6F-9BC7-3B689E62FE4CQ47852864-EAC4E908-56A0-4BD6-9CF0-A116B203AE39Q53063971-841E095A-2361-4DCA-93C6-829C416B74B7Q58823379-91556F93-243F-48A8-9D27-A64335D31C1F
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Efficacy and safety of sublingual immunotherapy.
@ast
Efficacy and safety of sublingual immunotherapy.
@en
type
label
Efficacy and safety of sublingual immunotherapy.
@ast
Efficacy and safety of sublingual immunotherapy.
@en
prefLabel
Efficacy and safety of sublingual immunotherapy.
@ast
Efficacy and safety of sublingual immunotherapy.
@en
P2093
P1476
Efficacy and safety of sublingual immunotherapy.
@en
P2093
Carlo Lombardi
Laura Guerra
Mercedes Pasquali
P304
3-12; quiz 12-3, 103
P356
10.1016/S1081-1206(10)61440-8
P577
2004-07-01T00:00:00Z